Introduction {#sec1_1}
============

Despite the continuous decrease in mortality rates from stroke in Portugal in the last two decades \[[@B1]\], disparities still remain in standardized rates among rural (77.1/100,000) and urban (71.8/100,000) areas in northern Portugal \[[@B2]\]. We have shown that this excess mortality in rural areas could be partially explained by a higher incidence of stroke and not by short-term case fatality, i.e., 30.1% in rural areas compared to 27.9% in the city of Porto in the first year following the first-ever-in-a-lifetime stroke (FELS) \[[@B3]\]. Rather than being a single pathological entity, stroke is a disease that includes distinct types having different incidence rates, risk profiles, management guidelines and outcomes that may lead to different disease burdens in different regions. Comparing the incidence of different stroke types as well as the risk profiles and long-term survival of patients with these stroke types in rural and urban populations may add important knowledge about their aetiology, prevention and prognosis. In order to accurately assess the incidence of different stroke types, studies investigating stroke incidences must meet ideal criteria \[[@B4],[@B5]\], such as the use of diagnostic brain imaging for the majority (ideally for all) of the patients \[[@B6]\]. In accordance to these criteria, a community-based prospective stroke registry was set up in northern Portugal \[[@B3]\]. The aim of this article is to present data on stroke types regarding incidence, risk profile and long-term survival for understanding the patterns of stroke in rural and urban populations.

Population and Methods {#sec1_2}
======================

The ACINrpc was a community-based study of the incidence and outcome of FELS and transient neurological focal symptoms and signs. The overall design of the project has been described in detail elsewhere \[[@B3]\]. In brief, the study population comprised 123,112 individuals registered and identified by a unique health service at five health centres on September 30, 1999 (mid-study period): 37,089 in rural areas and 80,023 in the city of Porto. This population was not significantly different from the corresponding geographic population \[[@B3]\]. Case ascertainment lasted from October 1, 1998, to September 30, 2000, and included both 'hot- and cold-pursuit data collection' using a variety of overlapping sources of information.

A study neurologist examined all suspected cases as soon as possible, and a CT was performed after the event. Medical records from hospitals and/or general practitioners (GP) were checked for details of any previous event and vascular risk factors (VRF). The principal investigator reviewed the information of each patient and classified the type of stroke; whenever appropriate, the classification was established after consensus between the neurologist who first examined the patient and the principal investigator.

All patients were followed up by neurologists at 3 months, 1 year and 7 years after the index event. The long-term follow-up began in September 2005, and every attempt was made to include all patients alive at the 1-year follow-up (fig. [1](#F1){ref-type="fig"}). The process began by updating the telephone contacts of the patients using health centre/hospital administrative files and all available information on patient medical records. This was followed by a first contact by phone made 15 days before the end of the 7-year period, and, when this failed, two letters were sent explaining the study purpose and suggesting a date for a consultation. Patients who collaborated but were not willing to complete the consultation were contacted by phone, and for those unable to come to the hospital, home visits were scheduled. For patients known to be deceased based on previous information, a family member/caregiver had to give information about the date and circumstances of death; otherwise, a search was done in the computer files held at the Northern Regional Health Administration. In case of death, information about date and circumstances of death was confirmed by manual inspection of written monthly reports at each health centre since current legislation forbids the use of death certificates for research purposes. This information was linked to existing clinical records for assigning the underlying cause of death, determined by a study neurologist. If no contact or information could be obtained, the patient was considered lost to follow-up.

Stroke was defined according to the World Health Organization \[[@B7]\], and stroke types were classified according to Sudlow and Warlow \[[@B5]\] as ischaemic stroke (IS), primary intracerebral haemorrhage (PICH) and subarachnoid haemorrhage (SAH). If no brain CT scan was performed within 30 days and no autopsy, lumbar puncture or angiography (in case of suspected SAH) results were available, stroke was classified as undetermined. For VRF, the following definitions were used: for hypertension, a history of high blood pressure (BP) or an anti-hypertensive treatment or systolic BP \>160 mm Hg and/or diastolic BP \>95 mm Hg on at least two different measures; for diabetes, a previous diagnosis/treatment of diabetes mellitus with oral anti-diabetic/insulin or fasting glycaemia \>126 mg/dl, postprandial glycaemia ≥200 mg/dl and/or a glucose tolerance test with values of glycaemia ≥200 mg/dl at the second hour; for hypercholesterolaemia, a previous diagnosis/treatment of hypercholesterolaemia or a serum total cholesterol level after 12 h of fasting ≥240 mg/dl; and for cardiac disease, a previous diagnosis of angina, myocardial infarction (MI) or atrial fibrillation by EKG confirmation, a previous diagnosis of a transient ischaemic attack (TIA), and smoking, categorized as never smoked, smoked regularly but not in the preceding 12 months (ex-smoker) and current smoker.

The Ethics Committee of the Hospital de Santo António, where the study coordination centre was located, approved the study. Informed consent was obtained from each participant, or from the next of kin when appropriate, before any clinical assessment. Since medical records are part of the National Health Service institutions, for follow-up purposes clinical files were used whenever the patient could not be contacted.

Statistical Analysis {#sec2_1}
--------------------

The distribution of patient characteristics at baseline according to stroke type is described. The crude incidence rates age-standardized to the Portuguese \[[@B8]\] and European populations \[[@B9]\] are reported, and the 95% confidence intervals (CI) were calculated by the Poisson distribution. The rural/urban ratios of VRF prevalence, stroke incidence and case fatality were calculated based on cross-tabulation and were used to compare rural and urban patients. The Kaplan-Meier estimates for the cumulative risk of death for stroke types over a period of 7 years after the index event were calculated in rural and urban patients. After checking the assumption of proportional hazards with the Schoenfeld\'s test, the rural/urban hazard ratios (HR) were calculated using a Cox model including the baseline risk profiles. Since this assumption failed when considering the time from the index event until death over the 7-year follow-up, this model was restricted to patients surviving the acute phase (28 days).

Results {#sec1_3}
=======

Of the 688 FELS (226 in rural and 462 in urban areas), 76.2% were IS (75.3 in rural vs. 77.9% in urban), 16.1% were PICH (16.3 vs. 14.6%), 3.3% SAH (2.7 vs. 3.7%) and 4.4% of undetermined stroke type (4.9 vs. 4.1%). More cases in rural compared to urban areas were ascertained by 'hot-pursuit' and sooner after the event. Nearly 56% of the patients were admitted to the hospital, with a similar proportion for IS in both rural and urban areas but a lower proportion of PICH in the rural area (69.7 vs. 96.2%). Overall, a CT scan was performed in 96.9% of the patients (not done in 12 urban and 9 rural patients) and in 70.3% within 24 h following the event.

Vascular Risk Profiles and Incidence {#sec2_2}
------------------------------------

Although patients were mostly women (58.7%), men predominated in rural areas (48.2 vs. 37.9%) either with an IS or PICH; patients from rural areas were older than patients from urban areas, especially those with an IS (table [1](#T1){ref-type="table"}). Hypertension was the most prevalent VRF (60.9%), whereas a previous TIA was seldom registered (8.6%). In general, the prevalence of VRF was lower in rural compared to urban patients, namely cardiac disease (IS and ICH), hypercholesterolaemia and smoking habits (IS).

The crude overall annual incidence rate per 1,000 population was 2.13 (95% CI, 1.95-2.31) for IS, 0.45 (95% CI, 0.37-0.53) for PICH, 0.09 (95% CI, 0.06-0.14) for SAH and 0.12 (95% CI, 0.08-0.17) for strokes of undetermined type; adjusted for the European population, these rates were 1.33 (95% CI, 1.19-1.48), 0.33 (95% CI, 0.25-0.41), 0.07 (95% CI, 0.04-0.12) and 0.07 (95% CI, 0.04-0.11), respectively (table [2](#T2){ref-type="table"}). The ratio of rates indicates that the incidence of IS in the youngest group (\<55 years) was lower in rural compared to urban populations, particularly in men (0.12; 95% CI, 0.02-0.91). The opposite trend was found among those aged 65-84 years (2.19; 95% CI, 1.37-3.49 in men and 1.65; 95% CI, 1.12-2.45 in women; results not shown). For the remaining stroke types, there was no evidence of differences in the age pattern of incidence rates between the rural and urban environment.

Short- and Long-Term Survival {#sec2_3}
-----------------------------

Of the 688 FELS patients, 204 (29.7%) died during the first year; the 7-year follow-up details for the 484 survivors are described in figure [1](#F1){ref-type="fig"}. Nine patients were lost after the 1-year follow-up (1.1-2.4 years), mostly because they had changed residence or went abroad (7 IS, 1 PICH and 1 SAH). Among the 209 (78.9%) patients examined by the neurologist, 21 (10%) were visited at their homes. The follow-up time ranged from 7 to 8.6 years.

By day 28, 59 (11.3%), 34 (30.6%), 7 (30.4%) and 11 (36.7%) patients had died after the first IS, PICH, SAH and undetermined stroke, respectively. There was no evidence of rural/urban differences in 28-day case fatality for the different stroke types, although IS tended to be less fatal among urban patients (10.3 vs. 13.1%), whereas PICH (33.3 vs. 24.2%) and SAH (35.3 vs. 16.7%) were less fatal among rural patients, corresponding to rural/urban ratios of 1.26 (95% CI, 0.77-2.06), 0.73 (95% CI, 0.37-1.44) and 0.47 (95% CI, 0.07-3.16), respectively. The cumulative risk of death at 7 years followed the same pattern: IS was less fatal in urban patients (57.4 vs. 61.5%), and PICH (67.4 vs. 64.6%) or SAH (61.2 vs. 33.3%) were less fatal in rural patients. The proportional mortality from stroke (first or recurrent stroke) was 74.8% (83/111) at 28 days, 48.0% (98/204) during the first year and 30.3% (128/423) at the end of follow-up after 7 years. Figure [2](#F2){ref-type="fig"} shows the risk of death at 28 days and by year for ischaemic and haemorrhage stroke (PICH and SAH), indicating a relatively constant yearly risk after 3 years in patients with an IS. Table [3](#T3){ref-type="table"} shows the independent baseline predictors of long-term survival after the acute phase. Besides age, diabetes (HR = 1.48; 95% CI, 1.15-1.92), MI/angina (HR = 1.80; 95% CI, 1.25-2.58), atrial fibrillation (HR = 1.47; 95% CI, 1.07-2.00) and being a current smoker (HR = 1.60; 95% CI, 1.13-2.28) increased the risk of death, whereas hypercholesterolaemia was a protective factor (HR = 0.45; 95% CI, 0.34-0.59). Stroke type and rural/urban residence were not associated with survival after the acute phase.

Discussion {#sec1_4}
==========

This is the first study to present a comprehensive picture of the burden of stroke among rural and urban populations, looking at the incidence of stroke types as well as at vascular risk profiles and long-term survival of patients. A high proportion of patients were ascertained by 'hot-pursuit'; almost all underwent a CT soon after the initial symptoms, thus improving the reliability of the results for the incidence of stroke types \[[@B5]\]. Differences in procedural aspects mostly stem from the organization of the National Health Service; health centre services are more readily available than hospital services for rural populations, and in the city this is mainly a question of choice since there are no barriers of distance. Almost all patients (91-92%) were seen at an 'emergency service'; however, in rural areas it was mostly at the health centre (open 24 h) and this is why these patients are more often observed within 3 h after the stroke. Nevertheless, in case of a PICH, there were fewer hospital admissions of rural compared with urban patients, though they remained in-patients in the health centre. Overall, the health services provided were similar for rural and urban patients, and based on previous studies we know that individuals living in rural areas are more prone to attend the family doctor at the health centre in case of most stroke warning signs than individuals living in urban areas \[[@B10]\].

There was a higher incidence of both IS and PICH in rural than urban areas. Nevertheless, the comparison of standardized rates obscured the differences in the incidence age pattern in the two populations, particularly in IS. On average, the first IS happened almost 3 years earlier in life among the urban population, leading to a higher IS incidence in the youngest group (\<55 years), especially in men, whereas for those aged 75-84 years living in rural areas, the average risk is almost twice as high than in the city. Although patients living in rural areas were older, they had, in general, less traditional VRF than patients living in urban areas, in particular cardiac disease and hypercholesterolaemia in patients with IS. The reduced information and awareness of VRF \[[@B10]\] in rural areas and the consequent lack of monitoring probably led to an under-reporting and/or under-diagnosis, mainly by GPs, since by description of ascertainment, health centre services are 'more accessible' in rural areas. On the other hand, our results go in the same direction than those from a Dutch study \[[@B11]\], in which self-reported health problems pointed to a better health in rural areas, although this could not be confirmed by the information available on GP records.

Figure [3](#F3){ref-type="fig"} shows the joint distribution of IS and PICH incidence across community-based studies with standardized rates (European population) or if data were available for calculation \[[@B12],[@B13],[@B14],[@B15],[@B16],[@B17],[@B18],[@B19],[@B20],[@B21],[@B22],[@B23],[@B24],[@B25],[@B26],[@B27],[@B28],[@B29],[@B30],[@B31],[@B32],[@B33],[@B34]\]. The IS incidence ranged from 57/100,000 in Menorca \[[@B29]\] to 255/100,000 in Mashhad \[[@B33]\], and the incidence of PICH ranged from 6/100,000 in Dijon \[[@B29]\] to 39/100,000 in Tbilisi \[[@B26]\]. Both Portuguese urban and rural populations are in the upper-right quadrant, indicating a relatively high incidence of both IS and PICH, with the first being only higher in Mashhad, Kaunas, Orebro and Matão \[[@B23],[@B28],[@B29],[@B33]\] and the latter in Mashhad, Tbilisi and Takashima \[[@B14],[@B26],[@B33]\]. Apart from Japan, studies in Greece \[[@B16]\], Italy \[[@B15],[@B19],[@B21]\] and Georgia \[[@B26]\] also reported a relatively high incidence of PICH, probably linked to the high prevalence of hypertension and excess of salt in the Mediterranean diet, similar to the Japanese diet with a high consumption of salted fish \[[@B35]\]. The standardized incidence of SAH in this group of studies ranged from 1 to 16/100,000 (median = 6/100,000), and the values in Portugal are close to the median. The comparison of the incidence of stroke types may be biased since the incidence of undetermined strokes could be as high as 59/100,000 (Trivandrum \[[@B30]\]), resulting from the low proportions of patients investigated with brain CT/MR scan and/or with a postmortem examination. Though we verified that there was no linear correlation between the year of the study and the standardized incidence of the different stroke types, the same could not be said in relation to the prevalence of VRF as a trend towards a lower incidence of PICH was found in repeated studies in Takashima \[[@B14]\], South London and Dijon \[[@B18],[@B29]\] (fig. [2](#F2){ref-type="fig"}). Nevertheless, in comparison with other studies, the prevalence of hypertension in patients from an urban area, representing a population-attributable risk for IS of 45.2% and for PICH of 73.6% \[[@B36]\], is among the highest (only exceeded in Oxfordshire \[[@B12]\] and Iquique \[[@B24]\]) for IS, and is the highest among Portuguese patients with PICH \[[@B15],[@B27],[@B37]\]; the same was found for diabetes mellitus, though the proportion of active smokers was relatively low compared to other studies \[[@B12],[@B15]\]. Besides traditional risk factors, environmental factors such as cold weather \[[@B38]\] and dietary habits may explain the relatively high variation shown in incidence rates.

There was no evidence of rural/urban differences in short- and long-term case fatality for the stroke types, though IS tended to be less fatal in patients from urban areas, whereas PICH and SAH were less fatal in patients from rural areas. The overall early case fatality after an IS (11.3%) found in this study is among the lowest values reported in all studies (range 10-26%) \[[@B12],[@B13],[@B15],[@B16],[@B17],[@B18],[@B19],[@B20],[@B21],[@B22],[@B23],[@B24],[@B25],[@B26],[@B28],[@B32],[@B34]\]; the values for PICH (30.6%) and SAH (30.4%) are also among the lowest within the respective ranges (20-61% for PICH \[[@B23],[@B25]\] and 8-50% for SAH \[[@B15],[@B18],[@B20]\]). The cumulative risk of death at 7 years follows an identical pattern as the 28-day case fatality in rural/urban populations, and the values are close to those reported in Perth after a FELS and higher than in Oxfordshire after an IS and lower for haemorrhagic stroke for a 5-year follow-up \[[@B39],[@B40]\]. As in these studies, the proportional mortality from stroke in this study abruptly decreased after the acute phase. Neither stroke type nor residence was a predictor of long-term survival after the acute phase, but most risk factors were at the same time prognostic factors. Besides age \<65 years, diabetes, atrial fibrillation, heart disease and smoking habits were predictors of poor survival, while hypercholesterolaemia was not. These results confirm recent findings \[[@B41],[@B42]\] and may justify why long-term survival is not associated with urban/rural environment. Since the stroke care chain is similar for patients from rural and urban areas, the older rural patients may have indeed a better survival than expected because risk/prognostic factors are less prevalent among them.

We have shown that the high incidence of stroke in rural compared to urban populations from northern Portugal is largely accounted for by the high incidence of cerebral infarcts, particularly in the rural elderly. The relatively better prognosis of IS and PICH in northern Portugal compared to other regions may result from the relatively high incidence of IS among the youngest age group living in the city as well as the relatively low prevalence of VRF in the eldest rural patients, pointing to different public health strategies. For better understanding the rural/urban differences in IS incidence, future analysis should be focused on the incidence of clinical subtypes of IS, aetiology and associated VRF.
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###### 

Ascertainment and patient characteristics (in %) by stroke type in urban and rural areas

                                          Urban         Rural         Ratio rural: urban                                                                                                   
  --------------------------------------- ------------- ------------- -------------------- ------------- ------------ ------------- ------------- ------------- ------ ------------ ------ ------------
  *First source of information*                                                                                                                                                            
  'Hot pursuit'                           76.4          56.4          23.5                 69.5          97.2         97.0          83.3          94.7          1.27   1.19--1.35   1.72   1.40--2.11
   Health centre                          5.5           --            --                   5.6           47.2         60.6          16.7          48.7                                     
   Hospital                               71.0          56.4          23.5                 63.9          50.0         36.4          66.7          46.0                                     
                                                                                                                                                                                           
  *Patient assessment*                                                                                                                                                                     
  Emergency services                      93.7          97.4          100.0                92.0          93.8         97.0          100.0         91.2          1.00   0.95--1.05   1.00   0.93--1.07
   \<3 h                                  36.8          50.0          52.9                 39.5          48.8         71.9          66.7          52.9          1.33   1.08--1.63   1.45   1.07--1.97
  In-patient admission                    50.3          96.2          100.0                57.8          50.6         69.7          100.0         52.2          1.01   0.84--1.20   0.72   0.58--0.91
  Time between onset and CT scan \<24 h   67.2          83.3          70.6                 69.1          67.0         66.7          50.0          65.9          1.00   0.88--1.13   0.80   0.62--1.04
                                                                                                                                                                                           
  *Patient characteristics*                                                                                                                                                                
  Male gender                             38.2          37.5          29.4                 37.9          48.9         51.5          --            48.2          1.28   1.05--1.56   1.39   0.89--2.15
  Mean age ± SD, years                    71.0 ± 13.1   67.2 ± 14.6   59.9 ± 19.0          70.3 ± 13.9   73.6 ± 9.4   67.5 ± 12.3   58.8 ± 19.7   72.5 ± 10.9                              
   \>65 years                             71.0          55.1          52.9                 68.2          84.1         60.6          50.0          80.1          1.18   1.08--1.30   1.10   0.78--1.54
  Hypertension                            62.9          69.2          52.9                 62.3          58.0         69.7          --            58.0          0.92   0.79--1.07   1.01   0.77--1.32
  Hypercholesterolemia                    41.4          28.2          17.6                 37.9          28.4         9.1           16.7          24.8          0.69   0.53--0.90   0.32   0.10--1.00
  Diabetes                                29.6          24.4          11.8                 27.1          21.6         9.1           --            18.6          0.73   0.53--1.01   0.37   0.12--1.18
  Atrial fibrillation                     17.2          3.8           --                   13.9          17.0         --            --            13.3          0.99   0.66--1.47   --     
  MI/angina                               11.5          10.3          5.9                  10.6          5.7          3.0           --            5.3           0.49   0.25--0.96   0.30   0.04--2.27
  TIA                                     12.4          2.6           --                   9.7           7.4          --            --            6.2           0.60   0.33--1.08   --     
  Smoking habits                                                                                                                                                                           
   Current smoker                         17.2          12.8          23.5                 16.9          8.0          6.1           --            8.0           0.46   0.27--0.80   0.47   0.11--2.04
   Ex-smoker                              9.2           5.1           --                   7.8           5.7          12.1          --            6.2           0.60   0.30--1.19   2.36   0.63--8.89

###### 

Age-specific annual incidence per 1,000 for stroke types in urban and rural northern Portugal (1998--2000)

  Age group (in years)                Person-years   IS    PICH    SAH          Undetermined                                                            
  ----------------------------------- -------------- ----- ------- ------------ -------------- ------ ------------ ---- ------ ------------ ---- ------ ------------
  Urban                                                                                                                                                 
   00--34                             68,706         2     0.03    0.00--0.11   2              0.03   0.00--0.11   1    0.01   0.00--0.08   0    0.00   0.00--0.05
   35--44                             24,806         15    0.60    0.34--1.00   4              0.16   0.04--0.41   3    0.12   0.02--0.35   0    0.00   0.00--0.15
   45--54                             23,500         24    1.02    0.65--1.52   9              0.38   0.18--0.73   3    0.13   0.03--0.37   2    0.09   0.01--0.31
   55--64                             19,584         48    2.45    1.81--3.25   17             0.87   0.51--1.39   1    0.05   0.00--0.28   0    0.00   0.00--0.19
   65--74                             19,544         102   5.22    4.21--6.23   20             1.02   0.63--1.58   6    0.31   0.11--0.67   5    0.26   0.08--0.60
   75--84                             11,812         108   9.14    7.42--10.9   14             1.19   0.65--1.99   1    0.08   0.00--0.47   6    0.51   0.19--1.11
   ≥85                                4,094          49    11.97   8.85--15.8   12             2.93   1.51--5.12   2    0.49   0.06--1.76   6    1.47   0.54--3.19
   All                                172,046        348   2.02    1.81--2.24   78             0.45   0.36--0.57   17   0.10   0.06--0.16   19   0.11   0.07--0.17
   ASRP                                                    1.63    1.44--1.82                  0.38   0.29--0.48        0.09   0.05--0.14        0.08   0.04--0.14
   ASRE                                                    1.26    1.10--1.44                  0.32   0.24--0.42        0.08   0.04--0.13        0.06   0.03--0.11
  Rural                                                                                                                                                 
   00--34                             33,690         1     0.03    0.00--0.17   0              0.00   0.00--0.11   1    0.03   0.00--0.17   0    0.00   0.00--0.11
   35--44                             9,972          2     0.20    0.02--0.72   0              0.00   0.00--0.37   1    0.10   0.00--0.56   1    0.10   0.00--0.56
   45--54                             8,360          2     0.24    0.03--0.86   7              0.84   0.34--1.72   0    0.00   0.00--0.44   0    0.00   0.00--0.44
   55--64                             8,386          19    2.27    1.36--3.54   6              0.72   0.26--1.56   1    0.12   0.00--0.66   0    0.00   0.00--0.44
   65--74                             8,350          64    7.66    5.90--9.79   10             1.20   0.57--2.20   2    0.24   0.03--0.86   3    0.36   0.07--1.05
   75--84                             4,152          71    17.10   13.4--21.6   8              1.93   0.83--3.80   1    0.24   0.01--1.34   4    0.96   0.26--2.47
   ≥85                                1,268          17    13.41   7.81--21.5   2              1.58   0.19--5.69   0    0.00   0.00--2.91   3    2.37   0.49--6.92
   All                                74,178         176   2.37    2.02--2.72   33             0.44   0.31--0.62   6    0.08   0.03--0.18   11   0.15   0.07--0.27
   ASRP                                                    2.12    1.79--2.45                  0.42   0.28--0.59        0.08   0.03--0.18        0.13   0.06--0.25
   ASRE                                                    1.51    1.23--1.79                  0.35   0.23--0.51        0.07   0.02--0.16        0.09   0.04--0.19
  All                                                                                                                                                   
   00--34                             102,396        3     0.03    0.01--0.09   2              0.02   0.00--0.07   2    0.02   0.00--0.07   0    0.00   0.00--0.04
   35--44                             34,778         17    0.49    0.28--0.78   4              0.12   0.03--0.29   4    0.12   0.03--0.29   1    0.03   0.00--0.16
   45--54                             31,860         26    0.82    0.53--1.20   16             0.50   0.29--0.82   3    0.09   0.02--0.28   2    0.06   0.01--0.23
   55--64                             27,970         67    2.40    1.86--3.04   23             0.82   0.52--1.23   2    0.07   0.01--0.26   0    0.00   0.00--0.13
   65--74                             27,894         166   5.95    5.05--6.86   30             1.08   0.73--1.54   8    0.29   0.12--0.56   8    0.29   0.12--0.56
   75--84                             15,964         179   11.21   9.57--12.9   22             1.38   0.86--2.09   2    0.13   0.02--0.45   10   0.63   0.30--1.15
   ≥85                                5,362          66    12.31   9.52--15.7   14             2.61   1.43--4.38   2    0.37   0.04--1.35   9    1.68   0.77--3.19
   All                                246,224        524   2.13    1.95--2.31   111            0.45   0.37--0.53   23   0.09   0.06--0.14   30   0.12   0.08--0.17
   ASRP                                                    1.76    1.60--1.93                  0.39   0.32--0.48        0.08   0.05--0.13        0.10   0.06--0.15
   ASRE                                                    1.33    1.19--1.48                  0.33   0.26--0.41        0.07   0.04--0.12        0.07   0.04--0.11
  Incidence rate ratios rural/urban                                                                                                                     
   00--54                                                  0.27    0.11--0.69                  1.05   0.43--2.57        0.64   0.13--3.09        1.12   0.10--12.4
   55--64                                                  0.92    0.54--1.57                  0.82   0.33--2.09        2.34   0.15--37.3        --     
   65--74                                                  1.47    1.08--2.01                  1.17   0.55--2.50        0.78   0.16--3.86        1.40   0.34--5.88
   75--84                                                  1.87    1.39--2.52                  1.63   0.68--3.87        2.84   0.18--45.5        1.90   0.54--6.72
   ≥85                                                     1.12    0.65--1.94                  0.54   0.12--2.40        --                       1.61   0.40--6.45
   All                                                     1.19    0.95--1.50                  1.10   0.69--1.75        0.89   0.32--2.50        1.62   0.62--4.27

ASRP = Age-standardized rate for the Portuguese population, 1999; ASRE = age-standardized rate for the European population.

###### 

HR for the association between factors at presentation and death among 28-day survivors

                                Univariate   Multivariate                                                
  ----------------------------- ------------ ---------------------------------------------------- ------ ----------------------------------------------------
  *Sociodemographics*                                                                                    
  Rural versus urban            1.18         0.93 -- 1.49                                         1.00   0.79 -- 1.29
  Men versus women              1.00         0.80 -- 1.26                                         0.94   0.71 -- 1.24
  Age \>65 versus ≤65 years     3.58         2.62 -- 4.90[^\*\*\*^](#T3F3){ref-type="table-fn"}   3.57   2.58 -- 4.95[^\*\*\*^](#T3F3){ref-type="table-fn"}
                                                                                                         
  *Risk factors (yes vs. no)*                                                                            
  Hypertension                  0.81         0.64 -- 1.02                                         0.86   0.68 -- 1.09
  Diabetes                      1.21         0.94 -- 1.56                                         1.48   1.15 -- 1.92[^\*\*^](#T3F2){ref-type="table-fn"}
  Atrial fibrillation           2.01         1.49 -- 2.72[^\*\*\*^](#T3F3){ref-type="table-fn"}   1.47   1.07 -- 2.00[^\*^](#T3F1){ref-type="table-fn"}
  MI/angina                     1.58         1.11 -- 2.23[^\*\*^](#T3F2){ref-type="table-fn"}     1.80   1.25 -- 2.58[^\*\*^](#T3F2){ref-type="table-fn"}
  TIA                           0.92         0.61 -- 1.37                                         0.99   0.66 -- 1.47
  Hypercholesterolaemia         0.46         0.36 -- 0.60[^\*\*\*^](#T3F3){ref-type="table-fn"}   0.45   0.34 -- 0.59[^\*\*\*^](#T3F3){ref-type="table-fn"}
  Smoking habits                                                                                         
   Ex-smoker                    0.65         0.42 -- 1.02                                         0.80   0.49 -- 1.31
   Current smoker               1.07         0.80 -- 1.43                                         1.60   1.13 -- 2.28[^\*\*^](#T3F2){ref-type="table-fn"}
                                                                                                         
  *Diagnosis (vs. IS)*                                                                                   
  PICH                          0.96         0.69 -- 1.34                                         1.12   0.79 -- 1.58
  SAH                           0.52         0.21 -- 1.25                                         0.63   0.26 -- 1.75
  Undetermined stroke type      1.15         0.63 -- 2.10                                         1.28   0.69 -- 2.36

p \< 0.05

p \< 0.01

p \< 0.001.

  Stroke type     0 -- 28 days   29 days to 1 year   1 -- 2 years   2 -- 3 years   3 -- 4 years   4 -- 5 years   5 -- 6 years   6 -- 7 years
  --------------- -------------- ------------------- -------------- -------------- -------------- -------------- -------------- --------------
  Ischemic                                                                                                                      
   At risk, n     524            465                 392            351            331            301            266            242
   Death, n (N)   59 (59)        73 (132)            38 (170)       17 (187)       30 (217)       35 (252)       23 (275)       28 (303)
   Risk, %        11.3           15.7                9.8            4.9            9.1            11.6           8.7            11.6
   95% CI         8.8 -- 14.3    12.7 -- 19.3        7.2 -- 13.1    3.1 -- 7.7     6.4 -- 12.6    8.5 -- 15.7    5.9 -- 12.7    8.1 -- 16.2
  Hemorrhagic                                                                                                                   
   At risk, n     134            93                  77             66             61             61             56             54
   Death, n (N)   41 (41)        16 (57)             9 (66)         5 (71)         0 (71)         5 (76)         2 (78)         7 (85)
   Risk, %        30.6           17.2                12.0           7.6            0.0            8.2            3.6            13.0
   95% CI         23.4 -- 38.9   10.9 -- 26.1        6.4 -- 21.3    3.3 -- 16.5    0.0 -- 5.9     3.6 -- 17.8    1.0 -- 12.1    6.4 -- 24.4
